Adult RBC’s contains a population of HbF (F-cells), which can differ between 0 and 14%. These F-cells may be the result of physiological variations during pregnancy or traits such as thalassemia, sickle cell anaemia or hereditary persistence of fetal haemoglobin. The detection (and thus enumeration) of fetal red blood cells (fRBCs) is used to calculate the extent of FMH, either in case of trauma with suspected placental injury or in the situation of a RhD incompatibility between the fetus and the mother. The amount of fRBCs is a measure for the prevention of hemolytic disease of the newborn using (prophylactic) anti-D therapy.

The FMH QuikQuant™ uses an anti-hemoglobin F monoclonal antibody and Propidium Iodide reagent. With less than 20 minutes of technologist time needed, FMH QuikQuant™ is a two-step wash technique requiring about 1 hour to complete.

• Detection of fetal hemoglobin (HbF) of as low as 0,06% fetal cells in maternal blood
• Results in 1 hour (20 minutes hands-on-time) with two single centrifuge steps
• IVD/CE

This product is distributed by IQ Products for Trillium Diagnostics.